7RD9
Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.159
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 22-ID |
| Synchrotron site | APS |
| Beamline | 22-ID |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2021-04-25 |
| Detector | DECTRIS EIGER2 X 16M |
| Wavelength(s) | 1 |
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 93.920, 62.004, 75.137 |
| Unit cell angles | 90.00, 105.87, 90.00 |
Refinement procedure
| Resolution | 34.320 - 1.910 |
| R-factor | 0.1887 |
| Rwork | 0.186 |
| R-free | 0.23330 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6b5l |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.19.1_4122) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.000 | 50.000 | 1.940 |
| High resolution limit [Å] | 1.910 | 5.180 | 1.910 |
| Rmerge | 0.177 | 0.069 | 0.555 |
| Rmeas | 0.201 | 0.084 | 0.631 |
| Rpim | 0.092 | 0.046 | 0.294 |
| Total number of observations | 142340 | ||
| Number of reflections | 30463 | 1120 | 1501 |
| <I/σ(I)> | 6.9 | ||
| Completeness [%] | 94.1 | 66.9 | 92.1 |
| Redundancy | 4.7 | 2.8 | 4.4 |
| CC(1/2) | 0.990 | 0.783 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.1 M sodium acetate trihydrate, pH 4.0, 10% w/v PEG4000 |






